Measles in Dallas: First case confirmed in young woman who was fully vaccinated
"The woman was contagious from May 30 through June 7. DCHHS said she has received care and officials are working to identify and notify individuals who may have been exposed," the media reported.
Possible measle exposure locations are said to be Lemma Coffee Plano, 1023 E 15th St, Plano, TX, 75074; and First Baptist Plano, 3665 W President George Bush Hwy, Plano, TX, 75075.
Measles has made a comeback
Measles might sound like one of those 'old-timey' diseases that only existed in history books, but trust me, it's still very much around—and it's not something to take lightly.
Caused by a highly contagious virus, measles spreads quickly. One sneeze or cough from an infected person can hang in the air or land on surfaces, ready to infect the next unsuspecting soul who walks by.
So, what are the
symptoms of measles
?
At first, it might seem like you just have a regular flu—fever, cough, runny nose, and red eyes. But then comes the telltale sign: a red, blotchy rash that usually starts on the face and then travels down the body. Before that rash shows up, you might even notice tiny white spots inside your mouth (called Koplik spots).
Once the rash appears, it usually sticks around for about a week, making you look and feel like you've had the roughest week ever.
Measles isn't just uncomfortable—it can be dangerous. Especially for babies, pregnant women, and people with weak immune systems. Complications can range from ear infections and diarrhea to pneumonia and even brain swelling (encephalitis). In severe cases, it can be fatal.
The real kicker? Measles is totally preventable.
One or two doses of the MMR vaccine (measles, mumps, and rubella) can give lifelong protection. Yet, outbreaks still happen, especially when vaccination rates drop. Some people skip vaccines due to misinformation or fear, but the science is pretty clear: the vaccine is safe, effective, and the best way to protect not just yourself, but everyone around you.
Once someone catches measles, there's no specific cure. Doctors usually just treat the symptoms—fluids, rest, and fever-reducing meds.
But prevention really is the best medicine here.
Why do vaccinated individuals get measles?
Sometimes people still get measles even after getting vaccinated, and it usually boils down to one of two things: either their body didn't build full immunity from the vaccine, or they didn't get both doses. The first dose gives about 93% protection, but the second bumps it up to around 97%. So if someone skipped the second shot, they're more at risk. Also, a tiny percent of people just don't respond to the vaccine for whatever reason—immune systems can be quirky like that.
But here's the good news: even if vaccinated folks do catch it, the symptoms are usually way milder.
So, while measles might seem like a thing of the past, it's not something to ignore. It's a fast-spreading, potentially dangerous virus that can mess up your week—or worse. Getting vaccinated, staying alert for symptoms, and acting fast if someone in your circle falls sick can make all the difference. Because nobody wants a virus that enters like a ninja, messes up your system, and leaves a rashy trail behind.
One step to a healthier you—join Times Health+ Yoga and feel the change
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
NDTV
6 days ago
- NDTV
Blind Canadian Woman, 75, Regains Vision After Bizarre 'Tooth-In-Eye Surgery'
After a decade of blindness, a 75-year-old Canadian woman regained her sight thanks to a bizarre operation that surgically implanted a tooth into her left eye socket. According to the New York Post, Gail Lane lost her sight ten years ago due to complications from an autoimmune disorder that caused scarring to her corneas. She was one of the three Canadians to receive the rare osteo-odonto keratoprosthesis procedure, known colloquially as tooth-in-eye surgery. According to the Post, Ms Lane underwent the rare and innovative procedure in February at Mount Saint Joseph Hospital in Vancouver. After 10 years without sight, she saw her partner's face and her dog's wagging tail for the very first time after the operation. "I can see lots of colour, and I can see outside now," the 75-year-old told CBS News. "The trees and the grass and flowers - it's a wonderful feeling to be able to see some of those things again," she added. Ms Lane said that in the weeks that followed the surgery, she gradually regained her ability to see. At first, she was just able to see light. Then, she could see movement and the wagging tail of her pet dog, Piper. Six months after the surgery was completed, Ms Lane saw the face of her beloved, Phil, whom she met after she lost her vision. "I'm starting to see facial features on other people as well, which is also pretty exciting," said Ms Lane. She said she hasn't been able to see her own face in detail yet, but hopes that too will come with time, aided by a new pair of glasses that she will be receiving soon. According to the outlet, ophthalmologist Dr Greg Moloney from Vancouver's Mount Saint Joseph Hospital was the first to bring the operation to Canada. He explained the procedure in detail. He said that the first step is to remove a tooth from the patient, which is then implanted in their cheek for a few months until it is surrounded by a strong connective tissue. Next, both the tooth and tissue are removed from the cheek, and a lens or plastic focusing telescope is fitted into a hole drilled into the pulpy mass, which is then stitched into the patient's eye socket. "It's a complex and strange operation, but it basically involves replacing the cornea," said Dr Moloney, who noted the goal is to create a "structure that is strong enough to hold onto the plastic focusing telescope but is not going to be rejected by the body." He went on to describe the recovery process as uncomfortable but not painful. Ms Lane said that she is thrilled to be able to do more things for herself now. "I'm hoping to have more mobility and independence in terms of short trips and walks here and there where I don't always have to have someone's arm for me to grab onto," she said. "I'm just looking forward, really, to seeing what I can do or do again - and trying to just be patient and let my brain adjust a bit because that's another big part of this," she added.
Mint
08-08-2025
- Mint
The race to find a measles treatment as infections surge
As a record number of people in the U.S. are sickened with measles, researchers are resurrecting the search for something long-deemed redundant: treatments for the viral disease. After the measles vaccine was introduced in the 1960s, cases of the disease plummeted. By 2000, federal officials had declared measles eliminated from the U.S. This success led to little interest in the development of treatments. But now, as vaccination rates fall and infections rise, scientists are racing to develop drugs they say could prevent or treat the disease in vulnerable and unvaccinated people. 'In America, we don't like being told what to do, but we like to have options for our medicine chest," said Marc Elia, chairman of the board of Invivyd, a Massachusetts-based drugmaker that started working on a monoclonal antibody for measles this spring. Scientists across the country including at biotechs Invivyd and Saravir Biopharma—and institutions such as Vanderbilt University Medical Center and Georgia State University—are in the early stages of measles-treatment development. The drugs are still a ways from becoming available to patients but could offer alternatives to people who are immunocompromised, don't respond to the measles vaccine or are vaccine skeptics. Some doctors and researchers warn that measles treatments could further drive the drop in vaccination. Nationally, 92.5% of kindergartners received the measles, mumps and rubella, or MMR, shot in the 2024-2025 school year, according to Centers for Disease Control and Prevention data. In 2019-2020, the vaccination rate was over 95%, which is the rate encouraged by health authorities to prevent community transmission of measles. More than 1,300 people, most of them unvaccinated, have been diagnosed with measles this year—a 33-year high. 'One of the motivations of getting the vaccine right now is that there are no treatments," said Dr. Joel Warsh, a pediatrician who says more research is needed into immunization safety. Still, Invivyd is betting its measles monoclonal antibody could help curb infections and outbreaks. Unlike the MMR vaccine, which is designed to train the body to make its own antibodies—proteins that help defeat specific pathogens—monoclonal antibodies are lab-made versions that can be delivered intravenously or as an injection and boost immunity immediately. Antibody treatments could treat someone who is sick or help prevent measles in people recently exposed to the virus. They could benefit newborns and immunocompromised people who can't be vaccinated, as well as the minority of people who don't respond to the vaccine or whose immunity has waned. The treatments could offer weeks or months of protection against measles, researchers said. 'Think of it like antivenom after a snake bite," said Erica Ollmann Saphire, chief executive of the La Jolla Institute for Immunology, whose lab is developing its own monoclonal antibodies for measles. 'Even people unsure about vaccines, if they are already sick with measles, getting an antibody treatment could be palatable." Saphire's lab has identified a few antibodies that have shown promise in animal tests. Invivyd said it hoped to have a drug candidate by the end of the year. At Vanderbilt University Medical Center, Dr. James Crowe, a pediatric infectious-disease specialist, has found success with a half-dozen antibodies that still need to be tested in people. In searching for a treatment, researchers have been forced to better understand measles, which Crowe said hadn't been as thoroughly studied as some other ailments because the vaccine had been so successful. The body's immune response to measles, for instance, hadn't been well understood. But he and other researchers now have a clearer picture of how measles antibodies work. Some block the virus from attaching to cells, while others interfere with a mechanism that allows the virus to fuse with cell membranes. Alternatives to vaccination could be especially appealing among some communities in Texas, where Dr. Ben Edwards practices family medicine and has treated hundreds of measles patients, he said. Many of them were from a Mennonite community hard-hit by a recent measles outbreak and where vaccination rates are low. 'They're going to want to look at the data though," he said. 'There's been a tremendous uptick in lack of trust in medicine." Edwards said he understands why many of his patients are skeptical of the MMR vaccine, which he said lacked adequate safety data. The MMR shot remains the best and only way to prevent measles, the CDC said. Multiple large-scale studies conducted over decades have proven the MMR vaccine to be very safe and effective, the agency said. Edwards said it makes sense to develop treatments—both drugs and alternative remedies—for measles so people have options. He said it was logical to think that more people would opt out of vaccination if effective treatments existed. Edwards, who had never treated a measles patient until this year, said he advised patients to take vitamin A supplements such as cod liver oil. He said he also treated about one-third of his measles patients with budesonide, an inhalable steroid medication used to treat asthma, to help alleviate respiratory problems. His approach attracted the attention of Health and Human Services Secretary Robert F. Kennedy Jr., who praised Edwards as an 'extraordinary" healer. Neither vitamin A supplements nor budesonide are considered measles treatments, said the Infectious Diseases Society of America, though budesonide can be used to treat complications from the illness. Some studies show that people with vitamin A deficiencies can get sicker from the virus, but there is no evidence that patients who aren't deficient will benefit from taking more of it, said John Lednicky, a microbiologist at the University of Florida. 'The typical American is not deficient," he said. 'And if you take too much, it will make you sick." Measles can cause severe acute disease and rarely death, but also 'immune amnesia," which causes the body to forget how to fight other infections, doctors said. Richard Plemper, a biomedical scientist at Georgia State University whose lab is developing an oral antiviral treatment for the virus family that includes measles, said he thinks people who want to get vaccinated will still do so, whether treatments are available or not. The antiviral he is working on, which is designed to block the ability of viruses including measles from replicating, has shown efficacy in animal experiments. But Plemper said he isn't sure how his lab will fund further research. Scheduled tests for the antiviral compound in dogs were canceled recently after National Institutes of Health funding was terminated. Saravir Biopharma, which was launched in July in collaboration with Columbia University to develop a measles monoclonal antibody, is banking on a continuing decline in vaccination rates to further fuel a need for measles treatments—and in turn, more investor interest. 'This is just the beginning," said Dr. Ron Moss, Saravir's CEO. 'I don't see public-health officials in this country turning around and saying everyone will need to get vaccinated in the next couple of years." Moss said Saravir's antibody treatment, which is designed to stop the measles virus from fusing with the body's cells, could be tested in people as soon as next year. Write to Dominique Mosbergen at
Time of India
05-08-2025
- Time of India
Vaccination gaps spark resurgence in measles and whooping cough: Global warning
A major study published in found that nearly 67 million children worldwide missed one or more routine vaccines between 2019 and 2022, with measles and pertussis (whooping cough) topping the list of high-risk outbreaks. Tired of too many ads? go ad free now The researchers called it "the largest sustained backslide in childhood immunisation in three decades." And now, we're seeing the effects. Diseases once under control are resurging across multiple countries. From India to the US and UK, measles and whooping cough are quietly creeping back faster, more widespread, and more dangerous than before. The common link? Falling vaccination rates, pandemic-related disruptions, and a worrying dip in public confidence around routine childhood immunisation. This article breaks down what's driving this spike in preventable diseases, who's most at risk, and what needs to change, urgently. Why measles is making a global resurgence Measles remains one of the most contagious diseases known, with an R₀ value of 12 to 18 meaning one case can trigger dozens of new infections in unprotected populations. After years of progress, measles cases jumped dramatically in 2023, reaching 10.3 million globally, a 20% rise from 2022. Nearly half of those infected were children under five. Millions of children missed their routine vaccinations during the COVID-19 pandemic. As of 2021, nearly 40 million children worldwide did not receive a single measles vaccine dose, creating widespread immunity gaps. The alarming rise of whooping cough alongside measles Whooping cough (pertussis) is also surging. From 2021 to 2024, reported cases in the U.S. soared by over 1,500%, with more than 7,100 cases already in 2025, almost double the prior year's tally. Tired of too many ads? go ad free now This resurgence closely tracks declines in DTaP vaccination rates. Even infants under six months who are most vulnerable are at heightened risk, and pertussis-related hospitalisations and fatalities are increasing. How declining immunisation fuels outbreaks A global analysis by BMJ and multiple health agencies found a post‑COVID surge in infections including measles, pertussis, tuberculosis, and polio, across more than 40 countries. Many faced up to ten-fold increases in disease rates, largely due to disrupted immunisation during the the U.S., MMR (measles, mumps, rubella) vaccination coverage fell to 92.5%, below the 95% needed for herd immunity. Texas reported a notable drop from 96.9% to 93.2% between 2019 and 2025. Why these diseases are dangerous for children Measles isn't just a rash and fever, it leads to complications like pneumonia, blindness, encephalitis, and long-term immune suppression. One in five infected children develops severe illness, and fatality rates rise significantly in under-fives and adults over 30. Pertussis causes violent coughing fits that can trigger vomiting, fractured ribs, and even life-threatening apnoea in infants. About a third of infected babies under one year require hospitalisation; fatality rates remain a serious concern. Quick snapshot: what's driving the resurgence in diseases Factor Impact Missed immunisations during COVID Created large pools of susceptible children Declining vaccine confidence and exemptions Undermined community protection Vaccination coverage dropping below 95% Allowed outbreaks to spread Inadequate surveillance in vulnerable populations Delayed detection and response What needs to change in the vaccination scene urgently Strengthen vaccine programmes worldwide, especially targeting underserved communities Restore trust in immunisation, counter misinformation, and enforce vaccine requirements Maintain surveillance and rapid outbreak response systems to identify emerging hotspots Ensure pregnant women and caregivers stay up to date with booster shots, especially for pertussis Scale up campaigns like India's Mission Indradhanush, which has improved childhood vaccine coverage dramatically in high-focus states like UP, Bihar and MP As measles and whooping cough resurface, the warning is clear: complacency isn't an option. These diseases can return with alarming speed when vaccine coverage dips, threatening children globally and straining healthcare systems. Restoring high vaccination rates, bolstering surveillance, and rebuilding public trust in immunisation are critical steps to preserve decades of progress and to prevent vaccine-preventable diseases from claiming more lives. Also read|
